Publications To Date


    Filter Publications

    PAGE 2 OF 9 | DISPLAYING 16 - 30 OF 134 RESULTS

    Sampath S. et. al., Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients, 10.18632/oncotarget.24397 , Oncotarget, Feb 02, 2018

    Revino L. et. al., Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation., 10.1172/JCI92812., JCI, Feb 01, 2018

    Ricca J.M. et. al., Pre-existing immunity to oncolytic virus potentiates its immunotherapeutic efficacy., 10.1016/j.ymthe.2018.01.019, Mol. Therapy, Jan 25, 2018

    Meraz I.M. et al., 2018 TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models., 10.1158/2326-6066.CIR-17-0273, Cancer Immunol Res. , Jan 17, 2018

    Ariyan C.E. et. al., 2018 Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade., 10.1158/2326-6066.CIR-17-0356, Cancer Immunol. Res., Jan 16, 2018

    Janse Van Rensburg H.J. et. al., The Hippo pathway component TAZ promotes immune evasion in human cancer through PD-L1., 10.1158/0008-5472.CAN-17-3139, Can. Res., Jan 16, 2018

    Luo N. et al., DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer, 10.1038/s41467-017-02630-w, Nat. Commun., Jan 16, 2018

    Zhao X. et. al., B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors, 10.1016/j.ymthe.2018.01.007, Mol. Therapy, Jan 16, 2018

    Penarando J. et. al., A role for endothelial nitric oxide synthase in intestinal stem cell proliferation and mesenchymal colorectal cancer, 10.1186/s12915-017-0472-5, BMC. Biol., Jan 10, 2018

    de Mingo Pulido A. et. al., TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer., 10.1016/j.ccell.2017.11.019., Cancer Cell, Jan 08, 2018

    Steggerda S.M. et al., Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment, 10.1186/s40425-017-0308-4, J. Immunother. Cancer, Dec 19, 2017

    Coelho M.A. et. al., Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA, 10.1016/j.immuni.2017.11.016, Immunity, Dec 19, 2017

    Zapka P. et al., Type, Frequency, and Spatial Distribution of Immune Cell Infiltrates in CNS Germinomas: Evidence for Inflammatory and Immunosuppressive Mechanisms., 10.1093/jnen/nlx106, J. Neuropathol. Exp. Neurol., Dec 11, 2017

    Oweida A. et. al., Response to stereotactic ablative radiotherapy in a novel orthotopic model of non-small cell lung cancer, 10.18632/oncotarget.22727, Oncotarget, Nov 28, 2017

    Boldrini L. et al., Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma, 10.1186/s12935-017-0474-y, Cancer Cell Int., Nov 17, 2017